HistoSonics CEO and President, Mike Blue

HistoSonics Appoints Mike Blue as CEO and Board Member; Completes First Close of a Series B Financing

This week, HistoSonics announced that Mike Blue joined the company as President, CEO, and board member of HistoSonics. Additionally, the company closed a Series B financing round of $8.3 million led by MVCA members Venture Investors, LLC, Wolverine Venture Fund and Grand Angels. ANN ARBOR, Mich., March 13, 2017 – HistoSonics, Inc. announced today that Mike… read more

NeuMoDx Announces Completion of Series B Financing

NeuMoDx Molecular, Inc. announced completion of its Series B financing, $21 million, which included investment from Baird Capital, Venture Investors, and existing investor Arboretum Ventures.

ArborMetrix Receives Additional $1.3 Million in Series B Financing From Renaissance Venture Capital Fund and Detroit Innovate Fund

ArborMetrix announced that it has increased its Series B financing by $1.3 million to allow Renaissance Venture Capital Fund and Detroit Innovate to participate.

Arboretum Ventures, RPM Ventures and Wolverine Venture Fund Finance ArborMetrix

ArborMetrix closed a $7 million in Series B financing from Arboretum Ventures, RPM Ventures and Wolverine Venture Fund.

Wolverine Venture Fund Joins Arboretum Ventures in Investment

The Wolverine Venture Fund recently joined Arboretum Ventures in a $25 million Series A investment in Sonitus Medical.

NEWS RELEASE: Michigan Venture Capital Association celebrated award winners, appoints 2011 Board of Directors at annual dinner Nov. 15

ANN ARBOR, Mich.—Celebrating “A Year of Exits”, the Michigan Venture Capital Association held its annual awards dinner for its members and guests November 15 in Ann Arbor.  The statewide membership organization honored several Michigan venture firms as well as venture capital recipient companies for their successes: MVCA “Michigan 100” Award winner Cerenis Therapeutics of Ann Arbor,… read more